Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis. 1990

P P De Deyn, and B Marescau, and R D Swartz, and R Hogaerth, and I Possemiers, and A Lowenthal
Laboratory of Neurochemistry, Born-Bunge Foundation, UIA, Antwerp, Belgium.

Guanidino compounds are increased in uremia and have been implicated as uremic toxins. The serum concentrations of 13 guanidino compounds and the clearances of 10 guanidino compounds were determined in 15 steady-state uremic patients treated with continuous ambulatory peritoneal dialysis. Guanidino compounds were determined using liquid cation-exchange chromatography with a sensitive fluorescence detection method. Standardized dialysis procedures were performed, including an overnight and a 3-hour dwell period. Guanidino compound levels did not significantly differ at the end of an overnight or a 3-hour exchange, indicating a steady-state blood chemistry for these substances in chronic ambulatory peritoneal dialysis. High levels were found for guanidinosuccinic acid, creatinine, guanidine and methylguanidine, while creatine and homoarginine levels were lower than in controls. Guanidinosuccinic acid, creatinine and methylguanidine reached levels associated with toxic effects in vitro. Significantly different clearances were found ranging from 4.02 +/- 1.08 ml/min for arginine to 7.94 +/- 2.76 ml/min for creatine during a 3-hour exchange.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D005260 Female Females
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014508 Urea A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids. Basodexan,Carbamide,Carmol

Related Publications

P P De Deyn, and B Marescau, and R D Swartz, and R Hogaerth, and I Possemiers, and A Lowenthal
November 1992, Clinical nephrology,
P P De Deyn, and B Marescau, and R D Swartz, and R Hogaerth, and I Possemiers, and A Lowenthal
January 1986, ASAIO transactions,
P P De Deyn, and B Marescau, and R D Swartz, and R Hogaerth, and I Possemiers, and A Lowenthal
September 1982, Medicina clinica,
P P De Deyn, and B Marescau, and R D Swartz, and R Hogaerth, and I Possemiers, and A Lowenthal
October 1990, The International journal of artificial organs,
P P De Deyn, and B Marescau, and R D Swartz, and R Hogaerth, and I Possemiers, and A Lowenthal
December 1995, Kidney international,
P P De Deyn, and B Marescau, and R D Swartz, and R Hogaerth, and I Possemiers, and A Lowenthal
November 1979, Kidney international,
P P De Deyn, and B Marescau, and R D Swartz, and R Hogaerth, and I Possemiers, and A Lowenthal
January 1983, Nephron,
P P De Deyn, and B Marescau, and R D Swartz, and R Hogaerth, and I Possemiers, and A Lowenthal
April 2014, Renal failure,
P P De Deyn, and B Marescau, and R D Swartz, and R Hogaerth, and I Possemiers, and A Lowenthal
May 1991, Clinical nephrology,
P P De Deyn, and B Marescau, and R D Swartz, and R Hogaerth, and I Possemiers, and A Lowenthal
January 1979, Transactions - American Society for Artificial Internal Organs,
Copied contents to your clipboard!